TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hyphens Pharma International Ltd. ( (SG:1J5) ) has provided an update.
Hyphens Pharma has expanded its agreement with Medac to include the commercialization of the Metoject® subcutaneous autoinjector pen in Thailand and Cambodia. This extension builds on an existing agreement covering Singapore, Malaysia, the Philippines, and Vietnam, further solidifying Hyphens Pharma’s presence in Southeast Asia and demonstrating its commitment to delivering innovative healthcare solutions in the region.
More about Hyphens Pharma International Ltd.
Hyphens Pharma International Ltd. is a leading specialty pharmaceutical and consumer healthcare group based in Singapore. The company focuses on providing innovative treatments and healthcare solutions across Southeast Asia.
Average Trading Volume: 240,365
Technical Sentiment Signal: Buy
Current Market Cap: S$111.3M
For an in-depth examination of 1J5 stock, go to TipRanks’ Overview page.